Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AVIENT CORPAVNT · Entity 4061 | Director | September 30, 2026 | October 02, 2026 |
| Corteva, Inc.CTVA · Entity 3006 | Director | April 28, 2026 | April 30, 2026 |
| Vylor Inc.VYLR · Entity 183857 | Director | October 01, 2026 | October 06, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AVIENT CORP
Report date September 30, 2026 · Filed October 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectDeferred Comp Plan | 52,985.662 |
Reported balance
After 2026-09-30 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2026-09-30 · Grant · Acquired 958 · Balance 52,985.662 F1: Includes shares acquired pursuant to a dividend reinvestment feature of the Avient Corporation Deferred Compensation Plan for Non-Employee Directors. |
| Common StockSEC Table I · non-derivative | Direct | 6,688 |
Reported balance
Holding disclosure · report date 2026-09-30 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 6,688 |
Filing footnotes · ownership attribution and instrument terms
F1: Includes shares acquired pursuant to a dividend reinvestment feature of the Avient Corporation Deferred Compensation Plan for Non-Employee Directors.
Corteva, Inc.
Report date April 28, 2026 · Filed April 30, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 18,467.3965 |
Reported balance
After 2026-04-28 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-04-28 · Grant · Acquired 2,350 · Balance 18,467.3965 F1: Includes acquisition of 158.0986 shares pursuant to dividend reinvestment. |
| Common StockSEC Table I · non-derivative | IndirectHeld in revocable living trust. | 2,500 |
Reported balance
Holding disclosure · report date 2026-04-28 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 2,500 |
Filing footnotes · ownership attribution and instrument terms
F1: Includes acquisition of 158.0986 shares pursuant to dividend reinvestment.
Vylor Inc.
Report date October 01, 2026 · Filed October 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| CommonSEC Table I · non-derivative | Direct | 18,551.2286 |
Reported balance
After 2026-10-01 transaction · row 1
1 source rowRow 1 · 2026-10-01 · Other · Acquired 18,551.2286 · Balance 18,551.2286 F1: On October 1, 2026, the Reporting Person received a dividend of one (1) share of Vylor Inc. ("Vylor") common stock for every one (1) share of Corteva Inc. ("Corteva") common stock held by the Reporting Person, and the Reporting Person's equity awards denominated in Corteva common stock were adjusted, in part, into equity awards denominated in Vylor common stock, in connection with the spin-off of Vylor from Corteva. This amount includes the Vylor common stock received in connection with the spin-off in an exempt transaction pursuant to Rule 16b-3, including restricted stock units and dividend equivalent units. |
| CommonSEC Table I · non-derivative | IndirectRevocable Living Trust | 2,500 |
Reported balance
After 2026-10-01 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2026-10-01 · Other · Acquired 2,500 · Balance 2,500 F2: On October 1, 2026, the Reporting Person received a dividend of one (1) share of Vylor Inc. ("Vylor") common stock for every one (1) share of Corteva Inc. ("Corteva") common stock held by the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: On October 1, 2026, the Reporting Person received a dividend of one (1) share of Vylor Inc. ("Vylor") common stock for every one (1) share of Corteva Inc. ("Corteva") common stock held by the Reporting Person, and the Reporting Person's equity awards denominated in Corteva common stock were adjusted, in part, into equity awards denominated in Vylor common stock, in connection with the spin-off of Vylor from Corteva. This amount includes the Vylor common stock received in connection with the spin-off in an exempt transaction pursuant to Rule 16b-3, including restricted stock units and dividend equivalent units.
F2: On October 1, 2026, the Reporting Person received a dividend of one (1) share of Vylor Inc. ("Vylor") common stock for every one (1) share of Corteva Inc. ("Corteva") common stock held by the Reporting Person.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
MONSANTO CO /NEW/
Report date June 07, 2018 · Filed June 07, 2018
Section 16 reporting ended · disclosed 2018-06-07. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2018-06-07 transaction · row 1
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 1 · 2018-06-07 · Disposition to issuer · Disposed 21,728 · Balance 0 F1: Pursuant to the terms of and subject to certain exceptions set forth in the Agreement and Plan of Merger, dated as of September 14, 2016 (the "Merger Agreement"), by and among Bayer Aktiengesellschaft ("Bayer"), KWA Investment Co. ("Merger Sub") and Monsanto Company (the "Company"), each share of common stock of the Company and each time- or performance-vesting restricted stock unit of the Company outstanding immediately prior to the effective time of the merger (the "Effective Time") was automatically converted into the right to receive $128.00 in cash, without interest (the "Merger Consideration"). F2: (Continued from Footnote 1) The Merger Consideration that is payable in respect of restricted stock units of the Company that were granted (a) prior to September 14, 2016 is fully vested as of the Effective Time or (b) after September 14, 2016 will vest based upon the vesting schedule applicable to the corresponding restricted stock units (subject to accelerated vesting in full upon a termination of employment without cause, for good reason or due to death, disability or retirement). Any Merger Consideration that is not paid at the Effective Time will begin accruing interest as of the Effective Time at the short-term federal rate. |
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2018-06-07 transaction · row 3
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 3 · 2018-06-07 · Disposition to issuer · Disposed 11,241 · Balance 0 F4: Represents restricted stock units. F1: Pursuant to the terms of and subject to certain exceptions set forth in the Agreement and Plan of Merger, dated as of September 14, 2016 (the "Merger Agreement"), by and among Bayer Aktiengesellschaft ("Bayer"), KWA Investment Co. ("Merger Sub") and Monsanto Company (the "Company"), each share of common stock of the Company and each time- or performance-vesting restricted stock unit of the Company outstanding immediately prior to the effective time of the merger (the "Effective Time") was automatically converted into the right to receive $128.00 in cash, without interest (the "Merger Consideration"). F2: (Continued from Footnote 1) The Merger Consideration that is payable in respect of restricted stock units of the Company that were granted (a) prior to September 14, 2016 is fully vested as of the Effective Time or (b) after September 14, 2016 will vest based upon the vesting schedule applicable to the corresponding restricted stock units (subject to accelerated vesting in full upon a termination of employment without cause, for good reason or due to death, disability or retirement). Any Merger Consideration that is not paid at the Effective Time will begin accruing interest as of the Effective Time at the short-term federal rate. |
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2018-06-07 transaction · row 4
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 4 · 2018-06-07 · Disposition to issuer · Disposed 19,787 · Balance 0 F5: Represents performance-based restricted stock units. F1: Pursuant to the terms of and subject to certain exceptions set forth in the Agreement and Plan of Merger, dated as of September 14, 2016 (the "Merger Agreement"), by and among Bayer Aktiengesellschaft ("Bayer"), KWA Investment Co. ("Merger Sub") and Monsanto Company (the "Company"), each share of common stock of the Company and each time- or performance-vesting restricted stock unit of the Company outstanding immediately prior to the effective time of the merger (the "Effective Time") was automatically converted into the right to receive $128.00 in cash, without interest (the "Merger Consideration"). F2: (Continued from Footnote 1) The Merger Consideration that is payable in respect of restricted stock units of the Company that were granted (a) prior to September 14, 2016 is fully vested as of the Effective Time or (b) after September 14, 2016 will vest based upon the vesting schedule applicable to the corresponding restricted stock units (subject to accelerated vesting in full upon a termination of employment without cause, for good reason or due to death, disability or retirement). Any Merger Consideration that is not paid at the Effective Time will begin accruing interest as of the Effective Time at the short-term federal rate. |
| Common StockSEC Table I · non-derivative | IndirectBy 401(k) Plan | 0 |
Reported balance
After 2018-06-07 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2018-06-07 · Disposition to issuer · Disposed 6,963 · Balance 0 F1: Pursuant to the terms of and subject to certain exceptions set forth in the Agreement and Plan of Merger, dated as of September 14, 2016 (the "Merger Agreement"), by and among Bayer Aktiengesellschaft ("Bayer"), KWA Investment Co. ("Merger Sub") and Monsanto Company (the "Company"), each share of common stock of the Company and each time- or performance-vesting restricted stock unit of the Company outstanding immediately prior to the effective time of the merger (the "Effective Time") was automatically converted into the right to receive $128.00 in cash, without interest (the "Merger Consideration"). F2: (Continued from Footnote 1) The Merger Consideration that is payable in respect of restricted stock units of the Company that were granted (a) prior to September 14, 2016 is fully vested as of the Effective Time or (b) after September 14, 2016 will vest based upon the vesting schedule applicable to the corresponding restricted stock units (subject to accelerated vesting in full upon a termination of employment without cause, for good reason or due to death, disability or retirement). Any Merger Consideration that is not paid at the Effective Time will begin accruing interest as of the Effective Time at the short-term federal rate. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $90.48 | Direct | 0 |
Reported balance
After 2018-06-07 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2018-06-07 · Disposition to issuer · Disposed 21,560 · Balance 0 F3: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $106.05 | Direct | 0 |
Reported balance
After 2018-06-07 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2018-06-07 · Disposition to issuer · Disposed 18,390 · Balance 0 F3: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $112.82 | Direct | 0 |
Reported balance
After 2018-06-07 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2018-06-07 · Disposition to issuer · Disposed 17,290 · Balance 0 F3: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $91.34 | Direct | 0 |
Reported balance
After 2018-06-07 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2018-06-07 · Disposition to issuer · Disposed 21,350 · Balance 0 F3: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $141.50 | Direct | 0 |
Reported balance
After 2018-06-07 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2018-06-07 · Disposition to issuer · Disposed 390 · Balance 0 F3: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest. |
| Phantom Share UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2018-06-07 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2018-06-07 · Disposition to issuer · Disposed 4,366 · Balance 0 F1: Pursuant to the terms of and subject to certain exceptions set forth in the Agreement and Plan of Merger, dated as of September 14, 2016 (the "Merger Agreement"), by and among Bayer Aktiengesellschaft ("Bayer"), KWA Investment Co. ("Merger Sub") and Monsanto Company (the "Company"), each share of common stock of the Company and each time- or performance-vesting restricted stock unit of the Company outstanding immediately prior to the effective time of the merger (the "Effective Time") was automatically converted into the right to receive $128.00 in cash, without interest (the "Merger Consideration"). F2: (Continued from Footnote 1) The Merger Consideration that is payable in respect of restricted stock units of the Company that were granted (a) prior to September 14, 2016 is fully vested as of the Effective Time or (b) after September 14, 2016 will vest based upon the vesting schedule applicable to the corresponding restricted stock units (subject to accelerated vesting in full upon a termination of employment without cause, for good reason or due to death, disability or retirement). Any Merger Consideration that is not paid at the Effective Time will begin accruing interest as of the Effective Time at the short-term federal rate. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the terms of and subject to certain exceptions set forth in the Agreement and Plan of Merger, dated as of September 14, 2016 (the "Merger Agreement"), by and among Bayer Aktiengesellschaft ("Bayer"), KWA Investment Co. ("Merger Sub") and Monsanto Company (the "Company"), each share of common stock of the Company and each time- or performance-vesting restricted stock unit of the Company outstanding immediately prior to the effective time of the merger (the "Effective Time") was automatically converted into the right to receive $128.00 in cash, without interest (the "Merger Consideration").
F2: (Continued from Footnote 1) The Merger Consideration that is payable in respect of restricted stock units of the Company that were granted (a) prior to September 14, 2016 is fully vested as of the Effective Time or (b) after September 14, 2016 will vest based upon the vesting schedule applicable to the corresponding restricted stock units (subject to accelerated vesting in full upon a termination of employment without cause, for good reason or due to death, disability or retirement). Any Merger Consideration that is not paid at the Effective Time will begin accruing interest as of the Effective Time at the short-term federal rate.
F3: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest.
F4: Represents restricted stock units.
F5: Represents performance-based restricted stock units.
Univar Solutions Inc.
Report date August 01, 2023 · Filed August 04, 2023
Section 16 reporting ended · disclosed 2023-08-04. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2023-08-01 transaction · row 1
1 source rowRow 1 · 2023-08-01 · Disposition to issuer · Disposed 8,333 · Balance 0 F1: Represents shares of Univar Solutions Inc. ("Univar") common stock disposed of in connection with the Agreement and Plan of Merger ("Merger Agreement"), dated as of March 13, 2023, by and among Univar and affiliates of funds managed by Apollo Global Management, Inc. In accordance with the Merger Agreement, at the effective time, each share of Univar common stock held by the reporting person was converted into the right to receive $36.15 in cash (the "Merger Consideration"). |
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2023-08-01 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2023-08-01 · Disposition to issuer · Disposed 28,886 · Balance 0 F2: In accordance with the Merger Agreement, at the effective time, each deferred stock unit award was cashed out for the Merger Consideration. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of Univar Solutions Inc. ("Univar") common stock disposed of in connection with the Agreement and Plan of Merger ("Merger Agreement"), dated as of March 13, 2023, by and among Univar and affiliates of funds managed by Apollo Global Management, Inc. In accordance with the Merger Agreement, at the effective time, each share of Univar common stock held by the reporting person was converted into the right to receive $36.15 in cash (the "Merger Consideration").
F2: In accordance with the Merger Agreement, at the effective time, each deferred stock unit award was cashed out for the Merger Consideration.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 01, 2026 Filed Oct 6, 2026 01:20 UTC | Vylor Inc. VYLR · Entity 183857 | OtherCommon | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-008265 · doc4.xml · nonDerivative · entry 2 Preete Kerry J · CIK 0001438256 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Revocable Living Trust Disclosed balance after: 2,500 F2 · shares: On October 1, 2026, the Reporting Person received a dividend of one (1) share of Vylor Inc. ("Vylor") common stock for every one (1) share of Corteva Inc. ("Corteva") common stock held by the Reporting Person. Read SEC document |
| October 01, 2026 Filed Oct 6, 2026 01:20 UTC | Vylor Inc. VYLR · Entity 183857 | OtherCommon | 18,551.2286 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-008265 · doc4.xml · nonDerivative · entry 1 Preete Kerry J · CIK 0001438256 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,551.2286 F1 · shares: On October 1, 2026, the Reporting Person received a dividend of one (1) share of Vylor Inc. ("Vylor") common stock for every one (1) share of Corteva Inc. ("Corteva") common stock held by the Reporting Person, and the Reporting Person's equity awards denominated in Corteva common stock were adjusted, in part, into equity awards denominated in Vylor common stock, in connection with the spin-off of Vylor from Corteva. This amount includes the Vylor common stock received in connection with the spin-off in an exempt transaction pursuant to Rule 16b-3, including restricted stock units and dividend equivalent units. Read SEC document |
| September 30, 2026 Filed Oct 2, 2026 17:31 UTC | AVIENT CORP AVNT · Entity 4061 | GrantCommon Stock | 958 | $0.00 | $0.00 |
DisclosureSEC source: 0001122976-26-000139 · form4.xml · nonDerivative · entry 1 Preete Kerry J · CIK 0001438256 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Deferred Comp Plan Disclosed balance after: 52,985.662 F1 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Avient Corporation Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| June 30, 2026 Filed Jul 2, 2026 15:47 UTC | AVIENT CORP AVNT · Entity 4061 | GrantCommon Stock | 1,049 | $0.00 | $0.00 |
DisclosureSEC source: 0001122976-26-000115 · form4.xml · nonDerivative · entry 1 Preete Kerry J · CIK 0001438256 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Deferred Comp Plan Disclosed balance after: 51,639.696 F1 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Avient Corporation Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| April 28, 2026 Filed Apr 30, 2026 21:46 UTC | Corteva, Inc. CTVA · Entity 3006 | GrantCommon Stock | 2,350 | $0.00 | $0.00 |
DisclosureSEC source: 0001438256-26-000001 · ownership.xml · nonDerivative · entry 1 Preete Kerry J · CIK 0001438256 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,467.3965 F1 · balance_after: Includes acquisition of 158.0986 shares pursuant to dividend reinvestment. Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 18:25 UTC | AVIENT CORP AVNT · Entity 4061 | GrantCommon Stock | 1,072 | $0.00 | $0.00 |
DisclosureSEC source: 0001122976-26-000083 · form4.xml · nonDerivative · entry 1 Preete Kerry J · CIK 0001438256 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Deferred Comp Plan Disclosed balance after: 50,201.339 F1 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Avient Corporation Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| December 31, 2025 Filed Jan 5, 2026 18:51 UTC | AVIENT CORP AVNT · Entity 4061 | GrantCommon Stock | 1,239 | $0.00 | $0.00 |
DisclosureSEC source: 0001122976-26-000019 · form4.xml · nonDerivative · entry 1 Preete Kerry J · CIK 0001438256 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Deferred Comp Plan Disclosed balance after: 48,724.48 F1 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Avient Corporation Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 16:03 UTC | AVIENT CORP AVNT · Entity 4061 | GrantCommon Stock | 1,192 | $0.00 | $0.00 |
DisclosureSEC source: 0001122976-25-000079 · form4.xml · nonDerivative · entry 1 Preete Kerry J · CIK 0001438256 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Deferred Comp Plan Disclosed balance after: 47,099.399 F1 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Avient Corporation Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| June 30, 2025 Filed Jul 2, 2025 18:17 UTC | AVIENT CORP AVNT · Entity 4061 | GrantCommon Stock | 1,187 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-018581 · form4.xml · nonDerivative · entry 1 Preete Kerry J · CIK 0001438256 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Deferred Comp Plan Disclosed balance after: 45,561.674 F1 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Avient Corporation Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| April 30, 2025 Filed May 2, 2025 21:04 UTC | Corteva, Inc. CTVA · Entity 3006 | GrantCommon Stock | 2,990 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-062921 · ownership.xml · nonDerivative · entry 1 Preete Kerry J · CIK 0001438256 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,959.2979 F1 · balance_after: Includes acquisition of 150.7425 shares pursuant to dividend reinvestment. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 19:41 UTC | AVIENT CORP AVNT · Entity 4061 | GrantCommon Stock | 1,055 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-011107 · form4.xml · nonDerivative · entry 1 Preete Kerry J · CIK 0001438256 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Deferred Comp Plan Disclosed balance after: 43,993.745 F1 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Avient Corporation Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 21:10 UTC | AVIENT CORP AVNT · Entity 4061 | GrantCommon Stock | 955 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-000393 · form4.xml · nonDerivative · entry 1 Preete Kerry J · CIK 0001438256 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Deferred Comp Plan Disclosed balance after: 42,648.535 F1 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Avient Corporation Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 30, 2024 Filed Oct 2, 2024 20:24 UTC | AVIENT CORP AVNT · Entity 4061 | GrantCommon Stock | 775 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-024906 · form4.xml · nonDerivative · entry 1 Preete Kerry J · CIK 0001438256 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Deferred Comp Plan Disclosed balance after: 41,478.273 F1 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Avient Corporation Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| June 28, 2024 Filed Jul 1, 2024 20:19 UTC | AVIENT CORP AVNT · Entity 4061 | GrantCommon Stock | 806 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-019553 · form4.xml · nonDerivative · entry 1 Preete Kerry J · CIK 0001438256 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Deferred Comp Plan Disclosed balance after: 40,459.752 F1 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Avient Corporation Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| April 26, 2024 Filed Apr 30, 2024 22:40 UTC | Corteva, Inc. CTVA · Entity 3006 | GrantCommon Stock | 3,100 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-050783 · ownership.xml · nonDerivative · entry 1 Preete Kerry J · CIK 0001438256 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,818.5554 F1 · balance_after: Includes acquisition of 115.6246 shares pursuant to dividend reinvestment. Read SEC document |
| March 29, 2024 Filed Apr 1, 2024 20:42 UTC | AVIENT CORP AVNT · Entity 4061 | GrantCommon Stock | 808 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-011609 · form4.xml · nonDerivative · entry 1 Preete Kerry J · CIK 0001438256 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Deferred Comp Plan Disclosed balance after: 39,420.192 F1 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Avient Corporation Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| December 29, 2023 Filed Jan 3, 2024 16:49 UTC | AVIENT CORP AVNT · Entity 4061 | GrantCommon Stock | 834 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-000255 · form4.xml · nonDerivative · entry 1 Preete Kerry J · CIK 0001438256 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Deferred Comp Plan Disclosed balance after: 38,358.977 F1 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Avient Corporation Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 29, 2023 Filed Oct 3, 2023 20:26 UTC | AVIENT CORP AVNT · Entity 4061 | GrantCommon Stock | 984 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-025215 · form4.xml · nonDerivative · entry 1 Preete Kerry J · CIK 0001438256 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Deferred Comp Plan Disclosed balance after: 37,258.097 F1 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Avient Corporation Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| August 01, 2023 Filed Aug 4, 2023 06:10 UTC | Univar Solutions Inc. UNVR · Entity 110826 | Disposition to issuerDeferred Stock Units · Derivative | 28,886 | $36.15 | $1,044,228.90 |
DisclosureSEC source: 0000899243-23-017779 · doc4.xml · derivative · entry 2 Preete Kerry J · CIK 0001438256 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 28,886 shares Expires not disclosed F2 · derivative.exercise_price: In accordance with the Merger Agreement, at the effective time, each deferred stock unit award was cashed out for the Merger Consideration. F2 · derivative.exercise_date: In accordance with the Merger Agreement, at the effective time, each deferred stock unit award was cashed out for the Merger Consideration. F2 · derivative.expiration_date: In accordance with the Merger Agreement, at the effective time, each deferred stock unit award was cashed out for the Merger Consideration. Read SEC document |
| August 01, 2023 Filed Aug 4, 2023 06:10 UTC | Univar Solutions Inc. UNVR · Entity 110826 | Disposition to issuerCommon Stock | 8,333 | $36.15 | $301,237.95 |
DisclosureSEC source: 0000899243-23-017779 · doc4.xml · nonDerivative · entry 1 Preete Kerry J · CIK 0001438256 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · shares: Represents shares of Univar Solutions Inc. ("Univar") common stock disposed of in connection with the Agreement and Plan of Merger ("Merger Agreement"), dated as of March 13, 2023, by and among Univar and affiliates of funds managed by Apollo Global Management, Inc. In accordance with the Merger Agreement, at the effective time, each share of Univar common stock held by the reporting person was converted into the right to receive $36.15 in cash (the "Merger Consideration"). F1 · price: Represents shares of Univar Solutions Inc. ("Univar") common stock disposed of in connection with the Agreement and Plan of Merger ("Merger Agreement"), dated as of March 13, 2023, by and among Univar and affiliates of funds managed by Apollo Global Management, Inc. In accordance with the Merger Agreement, at the effective time, each share of Univar common stock held by the reporting person was converted into the right to receive $36.15 in cash (the "Merger Consideration"). Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 17:25 UTC | AVIENT CORP AVNT · Entity 4061 | GrantCommon Stock | 863 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-019854 · form4.xml · nonDerivative · entry 1 Preete Kerry J · CIK 0001438256 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Deferred Comp Plan Disclosed balance after: 36,057.629 F1 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Avient Corporation Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| April 21, 2023 Filed Apr 25, 2023 20:48 UTC | Corteva, Inc. CTVA · Entity 3006 | GrantCommon Stock | 2,770 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-025561 · doc4.xml · nonDerivative · entry 1 Preete Kerry J · CIK 0001438256 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,602.9308 F1 · shares: Represents grant of restricted stock units with provisions limiting transfer until the first anniversary of the grant date. F2 · balance_after: Includes acquisition of shares pursuant to dividend reinvestment. Read SEC document |
| March 31, 2023 Filed Apr 3, 2023 20:06 UTC | AVIENT CORP AVNT · Entity 4061 | GrantCommon Stock | 857 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-011909 · form4.xml · nonDerivative · entry 1 Preete Kerry J · CIK 0001438256 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Deferred Comp Plan Disclosed balance after: 34,982.258 F1 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Avient Corporation Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| December 31, 2022 Filed Jan 3, 2023 19:11 UTC | AVIENT CORP AVNT · Entity 4061 | GrantCommon Stock | 1,040 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-000078 · form4.xml · nonDerivative · entry 1 Preete Kerry J · CIK 0001438256 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Deferred Comp Plan Disclosed balance after: 33,910.433 F1 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Avient Corporation Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 30, 2022 Filed Oct 3, 2022 17:40 UTC | AVIENT CORP AVNT · Entity 4061 | GrantCommon Stock | 1,139 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-023159 · form4.xml · nonDerivative · entry 1 Preete Kerry J · CIK 0001438256 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Deferred Comp Plan Disclosed balance after: 32,639.314 F1 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Avient Corporation Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| June 30, 2022 Filed Jul 1, 2022 18:01 UTC | AVIENT CORP AVNT · Entity 4061 | GrantCommon Stock | 880 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-018388 · form4.xml · nonDerivative · entry 1 Preete Kerry J · CIK 0001438256 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Deferred Comp Plan Disclosed balance after: 31,318.13 F1 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Avient Corporation Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| May 05, 2022 Filed May 5, 2022 20:30 UTC | Univar Solutions Inc. UNVR · Entity 110826 | GrantDeferred Stock Units · Derivative | 4,630 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-006605 · doc4.xml · derivative · entry 1 Preete Kerry J · CIK 0001438256 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,886 Underlying: Common Stock · 4,630 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit ("DSU") is equivalent to one share of common stock upon vesting. F2 · derivative.exercise_date: The Reporting Person has received an award of DSUs under the Company's 2020 Omnibus Equity Incentive Plan (the Plan). The DSUs become vested on the earlier to occur of (i) the first anniversary of the grant date or (ii) the date of the Company's annual meeting of stockholders in the year following the year of the grant date, provided that the Reporting Person continues as a director of the Company through such date and will be settled into shares of Common Stock on the earlier of (a) termination of the Reporting Person's service as director or; (b) change in control as defined in the Plan and in accordance with Section 409A of the Internal Revenue Code. F2 · derivative.expiration_date: The Reporting Person has received an award of DSUs under the Company's 2020 Omnibus Equity Incentive Plan (the Plan). The DSUs become vested on the earlier to occur of (i) the first anniversary of the grant date or (ii) the date of the Company's annual meeting of stockholders in the year following the year of the grant date, provided that the Reporting Person continues as a director of the Company through such date and will be settled into shares of Common Stock on the earlier of (a) termination of the Reporting Person's service as director or; (b) change in control as defined in the Plan and in accordance with Section 409A of the Internal Revenue Code. Read SEC document |
| April 29, 2022 Filed May 3, 2022 20:31 UTC | Corteva, Inc. CTVA · Entity 3006 | GrantCommon Stock | 2,950 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-026740 · doc4.xml · nonDerivative · entry 1 Preete Kerry J · CIK 0001438256 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,764.5892 F1 · shares: Represents grant of restricted stock units with provisions limiting transfer until the first anniversary of the grant date. F2 · balance_after: Includes acquisition of shares pursuant to dividend reinvestment. Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 20:09 UTC | AVIENT CORP AVNT · Entity 4061 | GrantCommon Stock | 717 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-011121 · form4.xml · nonDerivative · entry 1 Preete Kerry J · CIK 0001438256 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Deferred Comp Plan Disclosed balance after: 30,285.136 F1 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Avient Corporation Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| December 31, 2021 Filed Jan 3, 2022 18:03 UTC | AVIENT CORP AVNT · Entity 4061 | GrantCommon Stock | 627 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-000031 · form4.xml · nonDerivative · entry 1 Preete Kerry J · CIK 0001438256 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Deferred Comp Plan Disclosed balance after: 29,446 F1 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Avient Corporation Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 30, 2021 Filed Oct 1, 2021 20:07 UTC | AVIENT CORP AVNT · Entity 4061 | GrantCommon Stock | 744 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-026263 · form4.xml · nonDerivative · entry 1 Preete Kerry J · CIK 0001438256 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Deferred Comp Plan Disclosed balance after: 28,697 F1 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Avient Corporation Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| June 30, 2021 Filed Jul 1, 2021 12:23 UTC | AVIENT CORP AVNT · Entity 4061 | GrantCommon Stock | 669 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-020882 · form4.xml · nonDerivative · entry 1 Preete Kerry J · CIK 0001438256 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Deferred Comp Plan Disclosed balance after: 27,831 F1 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Avient Corporation Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| May 07, 2021 Filed May 11, 2021 21:48 UTC | Corteva, Inc. CTVA · Entity 3006 | GrantCommon Stock | 3,770 | $48.86 | $184,202.20 |
DisclosureSEC source: 0001209191-21-031805 · doc4.xml · nonDerivative · entry 1 Preete Kerry J · CIK 0001438256 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,770 F1 · shares: Represents annual grant of restricted stock units with provisions limiting transfer until retirement from service on the Issuer's board of directors. Read SEC document |
| May 06, 2021 Filed May 10, 2021 16:59 UTC | Univar Solutions Inc. UNVR · Entity 110826 | GrantDeferred Stock Units · Derivative | 5,764 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-007890 · doc4.xml · derivative · entry 1 Preete Kerry J · CIK 0001438256 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,256 Underlying: Common Stock · 5,764 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit ("DSU") is equivalent to one share of common stock upon vesting. F2 · derivative.exercise_date: The Reporting Person has received an award of DSUs under the Company's 2020 Omnibus Equity Incentive Plan (the Plan). The DSUs become vested on the earlier to occur of (i) the first anniversary of the grant date or (ii) the date of the Company's annual meeting of stockholders in the year following the year of the grant date, provided that the Reporting Person continues as a director of the Company through such date and will be settled into shares of Common Stock on the earlier of (a) termination of the Reporting Person's service as director or; (b) change in control as defined in the Plan and in accordance with Section 409A of the Internal Revenue Code. F2 · derivative.expiration_date: The Reporting Person has received an award of DSUs under the Company's 2020 Omnibus Equity Incentive Plan (the Plan). The DSUs become vested on the earlier to occur of (i) the first anniversary of the grant date or (ii) the date of the Company's annual meeting of stockholders in the year following the year of the grant date, provided that the Reporting Person continues as a director of the Company through such date and will be settled into shares of Common Stock on the earlier of (a) termination of the Reporting Person's service as director or; (b) change in control as defined in the Plan and in accordance with Section 409A of the Internal Revenue Code. Read SEC document |
| March 31, 2021 Filed Apr 1, 2021 20:21 UTC | AVIENT CORP AVNT · Entity 4061 | GrantCommon Stock | 682 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-012595 · form4.xml · nonDerivative · entry 1 Preete Kerry J · CIK 0001438256 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Deferred Comp Plan Disclosed balance after: 27,048 F1 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Avient Corporation Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| December 31, 2020 Filed Jan 4, 2021 17:21 UTC | AVIENT CORP AVNT · Entity 4061 | GrantCommon Stock | 804 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-000069 · form4.xml · nonDerivative · entry 1 Preete Kerry J · CIK 0001438256 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Deferred Comp Plan Disclosed balance after: 26,246 F1 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Avient Corporation Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 30, 2020 Filed Oct 1, 2020 18:18 UTC | AVIENT CORP AVNT · Entity 4061 | GrantCommon Stock | 1,202 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-025979 · form4.xml · nonDerivative · entry 1 Preete Kerry J · CIK 0001438256 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Deferred Comp Plan Disclosed balance after: 25,292 F1 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Avient Corporation Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| June 30, 2020 Filed Jul 1, 2020 16:05 UTC | AVIENT CORP POL · Entity 4061 | GrantCommon Stock | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-020545 · form4.xml · nonDerivative · entry 1 Preete Kerry J · CIK 0001438256 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Deferred Comp Plan Disclosed balance after: 23,910 F1 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the PolyOne Corporation Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| May 07, 2020 Filed May 11, 2020 18:47 UTC | Univar Solutions Inc. UNVR · Entity 110826 | GrantDeferred Stock Units · Derivative | 8,627 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-007436 · doc4.xml · derivative · entry 1 Preete Kerry J · CIK 0001438256 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,492 Underlying: Common Stock · 8,627 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit ("DSU") is equivalent to one share of common stock upon vesting. F2 · derivative.exercise_date: The Reporting Person has received an award of Deferred Stock Units (DSUs) under the Company's 2017 Omnibus Equity Incentive Plan (the Plan). The DSUs become vested on the earlier to occur of (i) the first anniversary of the grant date or (ii) the date of the Companys annual meeting of stockholders in the year following the year of the grant date, provided that the Reporting Person continues as a director of the Company through such date and will be settled into shares of Common Stock on the earlier of (a) termination of the Reporting Person's service as director or; (b) change in control as defined in the Plan and in accordance with Section 409A of the Internal Revenue Code. F2 · derivative.expiration_date: The Reporting Person has received an award of Deferred Stock Units (DSUs) under the Company's 2017 Omnibus Equity Incentive Plan (the Plan). The DSUs become vested on the earlier to occur of (i) the first anniversary of the grant date or (ii) the date of the Companys annual meeting of stockholders in the year following the year of the grant date, provided that the Reporting Person continues as a director of the Company through such date and will be settled into shares of Common Stock on the earlier of (a) termination of the Reporting Person's service as director or; (b) change in control as defined in the Plan and in accordance with Section 409A of the Internal Revenue Code. Read SEC document |
| March 31, 2020 Filed Apr 1, 2020 23:09 UTC | AVIENT CORP POL · Entity 4061 | GrantCommon Stock | 1,705 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-012475 · form4.xml · nonDerivative · entry 1 Preete Kerry J · CIK 0001438256 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Deferred Comp Plan Disclosed balance after: 22,451 F1 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the PolyOne Corporation Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 14:21 UTC | AVIENT CORP POL · Entity 4061 | GrantCommon Stock | 879 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-000314 · form4.xml · nonDerivative · entry 1 Preete Kerry J · CIK 0001438256 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Deferred Comp Plan Disclosed balance after: 20,633 F1 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the PolyOne Corporation Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 30, 2019 Filed Oct 1, 2019 19:36 UTC | AVIENT CORP POL · Entity 4061 | GrantCommon Stock | 1,001 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-029363 · form4.xml · nonDerivative · entry 1 Preete Kerry J · CIK 0001438256 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Deferred Comp Plan Disclosed balance after: 19,640 F1 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the PolyOne Corporation Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| June 30, 2019 Filed Jul 2, 2019 13:33 UTC | AVIENT CORP POL · Entity 4061 | GrantCommon Stock | 1,055 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-023323 · form4.xml · nonDerivative · entry 1 Preete Kerry J · CIK 0001438256 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Deferred Comp Plan Disclosed balance after: 18,527 F1 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the PolyOne Corporation Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| May 09, 2019 Filed May 10, 2019 16:32 UTC | Univar Solutions Inc. UNVR · Entity 110826 | GrantDeferred Stock Units · Derivative | 5,624 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-013050 · doc4.xml · derivative · entry 1 Preete Kerry J · CIK 0001438256 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,865 Underlying: Common Stock · 5,624 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit ("DSU") is equivalent to one share of common stock upon vesting F2 · derivative.exercise_date: The Reporting Person has recevied an award of Defferred Stock Units ("DSUs") under the Company's 2017 Omnibus Equity Incentive Plan (the "Plan"). The DSUs become vested on the one year anniversary of the grant date, provided that the Reporting Person continues as a director of the Company through such date and will be settled into shares of Common Stock on the earlier of (a) termination of the Reporting Person's service as director or; (b) change in contol as defined in the Plan and in accordance with Section 409A of the Internal Revenue Code. F2 · derivative.expiration_date: The Reporting Person has recevied an award of Defferred Stock Units ("DSUs") under the Company's 2017 Omnibus Equity Incentive Plan (the "Plan"). The DSUs become vested on the one year anniversary of the grant date, provided that the Reporting Person continues as a director of the Company through such date and will be settled into shares of Common Stock on the earlier of (a) termination of the Reporting Person's service as director or; (b) change in contol as defined in the Plan and in accordance with Section 409A of the Internal Revenue Code. Read SEC document |
| March 31, 2019 Filed Apr 2, 2019 20:04 UTC | AVIENT CORP POL · Entity 4061 | GrantCommon Stock | 1,108 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-014106 · form4.xml · nonDerivative · entry 1 Preete Kerry J · CIK 0001438256 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Deferred Comp Plan Disclosed balance after: 17,369 F1 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the PolyOne Corporation Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 21:29 UTC | AVIENT CORP POL · Entity 4061 | GrantCommon Stock | 1,149 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-000708 · form4.xml · nonDerivative · entry 1 Preete Kerry J · CIK 0001438256 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Deferred Comp Plan Disclosed balance after: 16,159 F1 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the PolyOne Corporation Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 30, 2018 Filed Oct 1, 2018 21:02 UTC | AVIENT CORP POL · Entity 4061 | GrantCommon Stock | 745 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-028792 · form4.xml · nonDerivative · entry 1 Preete Kerry J · CIK 0001438256 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Deferred Comp Plan Disclosed balance after: 14,952 F1 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the PolyOne Corporation Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 24, 2018 Filed Sep 24, 2018 16:34 UTC | Univar Solutions Inc. UNVR · Entity 110826 | PurchaseCommon Stock | 400 | $30.23 | $12,092.00 |
DisclosureSEC source: 0001225208-18-013722 · doc4.xml · nonDerivative · entry 2 Preete Kerry J · CIK 0001438256 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,333 F1 · balance_after: Mr. Preete made a series of acquistions that resulted in him owning a total of 8,333 shares of the Issuer's common stock. Read SEC document |
| September 24, 2018 Filed Sep 24, 2018 16:34 UTC | Univar Solutions Inc. UNVR · Entity 110826 | PurchaseCommon Stock | 7,850 | $30.24 | $237,384.00 |
DisclosureSEC source: 0001225208-18-013722 · doc4.xml · nonDerivative · entry 1 Preete Kerry J · CIK 0001438256 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,933 Read SEC document |
| June 30, 2018 Filed Jul 2, 2018 20:51 UTC | AVIENT CORP POL · Entity 4061 | GrantCommon Stock | 660 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-022296 · form4.xml · nonDerivative · entry 1 Preete Kerry J · CIK 0001438256 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Deferred Comp Plan Disclosed balance after: 14,155 F1 · balance_after: Includes 51 shares acquired on April 5, 2018 pursuant to a dividend reinvestment feature of the PolyOne Corporation Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.